Cargando…

Computational strategies towards developing novel SARS-CoV-2 M(pro) inhibitors against COVID-19

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains to be a serious threat due to the lack of a specific therapeutic agent. Computational methods are particularly suitable for rapidly fight against SARS-CoV-2. This present research aims to systematica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ding, Tong, Jian-Bo, Zhang, Xing, Xiao, Xue-Chun, Bian, Shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398673/ https://www.ncbi.nlm.nih.gov/pubmed/34483363 http://dx.doi.org/10.1016/j.molstruc.2021.131378

Ejemplares similares

Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors
por: TONG, Jian-Bo, et al.
Publicado: (2021)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 M(pro)
por: Hussain, A., et al.
Publicado: (2022)

Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 M(pro)
por: Wang, Zhengyuan, et al.
Publicado: (2021)

Identification of M(pro) inhibitors of SARS-CoV-2 using structure based computational drug repurposing
por: Nath, Virendra, et al.
Publicado: (2021)

Computationally driven discovery of SARS-CoV-2 M(pro) inhibitors: from design to experimental validation
por: El Khoury, Léa, et al.
Publicado: (2022)

Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M(pro)) of SARS-CoV-2
por: Silva, José Rogério A., et al.
Publicado: (2021)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

Luminescent Assay for the Screening of SARS‐CoV‐2 M(Pro) Inhibitors
por: Sondag, Daan, et al.
Publicado: (2022)

Computational investigation of natural compounds as potential main protease (M(pro)) inhibitors for SARS-CoV-2 virus
por: Patel, Chirag N., et al.
Publicado: (2022)

Discovery of highly potent SARS-CoV-2 M(pro) inhibitors based on benzoisothiazolone scaffold
por: Chen, Weixiong, et al.
Publicado: (2022)

M(pro)-targeted anti-SARS-CoV-2 inhibitor-based drugs
por: She, Zhuxin, et al.
Publicado: (2023)

Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M(pro) via combinatorial molecular simulation calculations
por: Bharadwaj, Shiv, et al.
Publicado: (2020)

Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M(pro) inhibitor
por: Kakhar Umar, Abd., et al.
Publicado: (2023)

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M(pro) Inhibitors
por: Fassi, Enrico M. A., et al.
Publicado: (2023)

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
por: Gao, Shenghua, et al.
Publicado: (2022)

In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-M(Pro) inhibitors
por: Aljuhani, Ateyatallah, et al.
Publicado: (2022)

Review on development of potential inhibitors of SARS-CoV-2 main protease (M(Pro))
por: Katre, Soumya Gulab, et al.
Publicado: (2022)

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M(pro)
por: Citarella, Andrea, et al.
Publicado: (2023)

Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 M(Pro) and PL(Pro)
por: Kattula, Bhavita, et al.
Publicado: (2023)

SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model
por: Qiao, Jingxin, et al.
Publicado: (2021)

GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 M(pro)
por: More-Adate, Pallavi, et al.
Publicado: (2022)

Computer-aided drug design for virtual-screening and active-predicting of main protease (M(pro)) inhibitors against SARS-CoV-2
por: Dai, Renhui, et al.
Publicado: (2023)

Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M(pro) and cathepsin L
por: Sacco, Michael Dominic, et al.
Publicado: (2020)

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L
por: Sacco, Michael Dominic, et al.
Publicado: (2020)

A new generation M(pro) inhibitor with potent activity against SARS-CoV-2 Omicron variants
por: Huang, Chong, et al.
Publicado: (2023)

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro))
por: Sayed, Ahmed M., et al.
Publicado: (2020)

Newly synthesized M(pro) inhibitors as potential oral anti-SARS-CoV-2 agents
por: Li, Lin, et al.
Publicado: (2021)

Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M(pro) inhibitors
por: Malla, Tika R., et al.
Publicado: (2021)

SARS-CoV-2 M(pro): A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
por: Citarella, Andrea, et al.
Publicado: (2021)

Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 M(Pro) inhibitors
por: Airas, Justin, et al.
Publicado: (2022)

Interaction of GC376, a SARS-COV-2 M(PRO) inhibitor, with model lipid membranes
por: Klacsová, Mária, et al.
Publicado: (2022)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023)

Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M(pro) Inhibitors
por: Jacobs, Leon, et al.
Publicado: (2023)

Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors
por: Horchani, Mabrouk, et al.
Publicado: (2022)

Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M(pro) by QM/MM computational methods
por: Świderek, Katarzyna, et al.
Publicado: (2020)

Computational investigation on the antioxidant activities and on the M(pro) SARS-CoV-2 non-covalent inhibition of isorhamnetin
por: Spiegel, Maciej, et al.
Publicado: (2023)

Evaluation of in vitro antiviral activity of SARS-CoV-2 M(pro) inhibitor pomotrelvir and cross-resistance to nirmatrelvir resistance substitutions
por: Tong, Xiao, et al.
Publicado: (2023)

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
por: Falade, Victoria Adeola, et al.
Publicado: (2021)

DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors
por: Chamakuri, Srinivas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m4dr3hv55cscjcmqcl00frdnn7